Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jamesw
    Junior Member
    • Jul 2010
    • 1

    #1

    PhD position in metagenomics at UCalgary

    Project Title
    The Microbiology and Immunology of Post-Operative Crohn’s Disease Recurrence

    Co-Supervisors
    Drs. Kevin Rioux and James Wasmuth

    Description
    We are seeking a graduate student to join a collaborative project investigating the gut microbiota of Crohn’s disease (CD) patients. The primary role of the student is the bioinformatics analysis of next-generation sequence data to discover baseline composition and dynamics of bacterial communities that define recurrence or stable remission after intestinal resection in patients with CD. The student will also be responsible for processing surgical and endoscopic mucosal biopsies and ensuring universally high-quality specimens from storage to end-use.

    Ideally, we are seeking a student who has a strong interest in bioinformatics and statistical analysis of genomics data. Experience with the Linux operation system is extremely desirable.

    The student will be co-supervised by Dr. Kevin Rioux, a clinician and specialist in Inflammatory Bowel Disease (IBD) and Dr. James Wasmuth, who runs a research group specializing in bioinformatics and host-pathogen interactions. In addition, the student will benefit by being part of the Alberta IBD Consortium (http://albertaibdconsortium.ca/trainees).

    The University of Calgary is a research-intensive, comprehensive university that supports innovation in research, education and service to the community. Calgary is a vibrant, multicultural city with a population of 1,000,000. It is located near the Rocky Mountains, Banff National Park and Lake Louise and offers an enormous opportunity for outdoor activities both in winter and summer.

    If you are interested in applying to join this project, please email Dr. Rioux ([email protected]) with a brief letter explaining your motivation and research interests, attaching your CV and the contact details for three references.

    Applications for this position are currently being accepted for admission into the graduate program in January, 2012.

    About AIDBC
    The Alberta Inflammatory Bowel Disease Consortium (Alberta IBD Consortium) is an interdisciplinary team of over 50 clinicians, scientists and trainees from the Universities of Calgary, Alberta, Toronto, Lethbridge and Manitoba who have joined together to study the role that genetic, microbial and environmental factors play in the development and perpetuation of IBD. The team is comprised of specialists from a wide spectrum of fields including medicine, epidemiology, microbiology, veterinary medicine, genetics and other health sciences disciplines who are working together in a novel collaborative manner in order to address this complex and devastating family of diseases. This team is supported by a 5-year, $5 million grant from Alberta Innovates-Health Solutions (formerly the Alberta Heritage Foundation for Medical Research), and is presently recruiting a Ph.D. student at the University of Calgary.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...